Lack of p73 mutations and late occurrence of p73 allelic deletions in melanoma tissues and cell lines

International Journal of Cancer

Volumn 82, Issue 4, 1999, Pages 583-586

  Schittek, Birgit ^a   Sauer, Birgit ^a   Garbe, Claus ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN P73; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CANCER CELL CULTURE; CHROMOSOME 1P; GENE DELETION; GENE EXPRESSION; GENE LOCUS; GENE LOSS; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; MELANOCYTIC NEVUS; MELANOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN METASTASIS; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

ALLELES; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; GENE DELETION; GENES, TUMOR SUPPRESSOR; HUMANS; MELANOMA; NEVUS, PIGMENTED; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0032856719     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990812)82:4<583::AID-IJC18>3.0.CO;2-G     Document Type: Article

References (20)

1. BARLOW, D.P., Gametic imprinting in mammals. Science, 270, 1610-1613 (1995).
2. CARON, H., AND 12 OTHERS, Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification. Hum. mol. Genet., 4, 535-539 (1995).
3. CARON, H., VAN SLUIS, P., VAN HOEVE, M., DE KRAKER, J., BRAS, J., SLATER, R., MANNENS, M., VOUTE, P.A., WESTERVELD, A., and VERSTEEG, R., Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification [published erratum appears in Nature (Genet.), 4, 431, (1993)]. Nature (Genet.), 4, 187-190 (1993).
4. CASTRESANA, J.S., RUBIO, M.P., VAZQUEZ, J.J., IDOATE, M., SOBER, A.J., SEIZINGER, B.R., and BARNHILL, R.L., Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma. Int. J. Cancer, 55, 562-565 (1993).
5. CHENG, J.M., HIEMSTRA, J.L., SCHNEIDER, S.S., NAUMOVA, A., CHEUNG, N.K., COHN, S.L., DILLER, L., SAPIENZA, C., and BRODEUR, G.M., Preferential amplification of the paternal allele of the N-myc gene in human neuroblastomas. Nature (Genet.), 4, 191-194 (1993).
6. CHO, Y., GORINA, S., JEFFREY, PD and PAVLETICH, NP., Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265, 346-355 (1994).
7. DRACOPOLI, N.C., HARNETT, P., BALE, S.J., STANGER, B.Z., TUCKER, M.A., HOUSMAN, D.E., and KEFFORD, R.F., Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc. nat. Acad. Sci. (Wash.), 86, 4614-4618 (1989).
8. FLORENES, V.A., OYJORD, T., HOLM, R., SKREDE, M., BØRRESEN, A.L., NESLAND, J.M., and FODSTAD, O., TP53 allele loss, mutations and expression in malignant melanoma. Brit. J. Cancer, 69, 253-259 (1994).
9. GENUARDI, M., TSIHIRA, H., ANDERSON, D.E., and SAUNDERS, G.F. Distal deletion of chromosome Ip in ductal carcinoma of the breast. Amer. J. Hum. Genet., 45, 73-82 (1989).
10. HARTMANN, A., BLASZYK, H., CUNNINGHAM, J.S., MCGOVERN, R.M., SCHROEDER, J.S., HELANDER, S.D., PITTELKOW, MR., SOMMER, S.S., and KOVACH, J.S., Overexpression and mutations of p53 in metastatic malignant melanomas. Int. J. Cancer, 67, 313-317 (1996).
11. JOST, C.A., MARIN, M.C., and KAELIN, W.G., Jr. p73 is a human p53-related protein that can induce apoptosis. Nature (Lond.), 389, 191-194 (1997).
12. KAGHAD, M. and 12 OTHERS, Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell, 90, 809-819 (1997).
13. MAI, M., YOKOMIZO, A., QIAN, C., YANG, P., TINDALL, D.J., SMITH, D.I., and LIU, W., Activation of p73 silent allele in lung cancer. Cancer Res., 58, 2347-2349 (1998).
14. NOMOTO, S., HARUKI, N., KONDO, M., KONISHI, H., and TAKAHASHI, T., Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res., 58, 1380-1383 (1998).
15. PAPP, T., JAFARI, M., and SCHIFFMANN, D., Lack of p53 mutations and loss of heterozygosity in non-cultured human melanocytic lesions. J. Cancer Res. clin. Oncol., 122, 541-548 (1996).
16. POETSCH, M., WOENCKHAUS, C., DITTBERNER, T., PAMBOR, M., LORENZ, G., and HERRMANN, F.H. An increased frequency of numerical chromosomal abnormalities and 1p36 deletions in isolated cells from paraffin sections of malignant melanomas by means of interphase cytogenetics. Cancer Genet. Cytogenetics, 104, 146-152 (1998).
17. SCHWAB, M., PRAML, C., and AMLER, L.C., Genomic instability in 1p and human malignancies. Genes Chromosomes Cancer, 16, 211-229 (1996).
18. TAKAHASHI, H., ICHIMIYA, S., NIMURA, Y., WATANABE, M., FURUSATO, M., WAKUI, S., YATANI, R., AIZAWA, S., and NAKAGAWARA, A., Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma. Cancer Res., 58, 2076-2077 (1998).
19. WALKER, G.J., PALMER, J.M., WALTERS, M.K., and HAYWARD, N.K., A genetic model of melanoma tumorigenesis based on allelic losses. Genes Chromomes Cancer, 12, 134-141 (1995).
20. YEH, S.H., CHEN, P.J., CHEN, H.L., LAI, M.Y., WANG, C.C., and CHEN, D.S., Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res., 54, 4188-4192 (1994).